Xenetic Biosciences Stock (NASDAQ: XBIO) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 537.000 / 5.976K |
Day Range | - - - |
52 Wk Range | 2.550 - 5.970 |
Market Cap | $5.778M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | 0.11% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Xenetic Biosciences (NASDAQ: XBIO) through any online brokerage.
Other companies in Xenetic Biosciences’s space includes: Alzamend Neuro (NASDAQ:ALZN), Synaptogenix (NASDAQ:SNPX), NexImmune (NASDAQ:NEXI), Portage Biotech (NASDAQ:PRTG) and Trevena (NASDAQ:TRVN).
The latest price target for Xenetic Biosciences (NASDAQ: XBIO) was reported by HC Wainwright & Co. on Tuesday, May 16, 2023. The analyst firm set a price target for 0.00 expecting XBIO to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Xenetic Biosciences (NASDAQ: XBIO) is $3.75 last updated March 28, 2024 at 6:57 PM EDT.
There are no upcoming dividends for Xenetic Biosciences.
Xenetic Biosciences’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Xenetic Biosciences.
Xenetic Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.